Drug discovery methods
First Claim
Patent Images
1. A method for identifying a drug discovery target which comprises:
- (a) providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
(b) querying the database to identify a disease-related pathway; and
(c) identifying the biological interactions and actor concepts in the disease-related pathway whereby each of the actor concepts involved in each such reaction is a drug discovery target.
2 Assignments
0 Petitions
Accused Products
Abstract
Method for identifying disease-related pathways that can used to identify discovery targets, to identify new uses for known drugs, to identify markers for drug response, and related purposes.
82 Citations
53 Claims
-
1. A method for identifying a drug discovery target which comprises:
-
(a) providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
(b) querying the database to identify a disease-related pathway; and
(c) identifying the biological interactions and actor concepts in the disease-related pathway whereby each of the actor concepts involved in each such reaction is a drug discovery target. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 51)
-
-
26. A method for evaluating user-supplied genomics data using a structured database that permits the computation of complex relationships among genes and/or gene products contained in the database, comprising:
-
(a) defining a profile model based on one or more profile definition criterion;
(b) building a collection of profiles according to the profile model;
(c) identifying one or more profiles that overlap at least a portion of the user-supplied genomics data and determining, for each such overlapped profile, whether the overlap is statistically significant; and
(d) analyzing one or more statistically significant profiles together with the user-supplied genomics data including inspecting database-asserted biological interactions embodied in the one or more statistically significant profiles. - View Dependent Claims (27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)
-
-
45. A method for identifying a new use for a known therapy comprising the steps of providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
- querying the database to identify a disease-related pathway comprising a known therapy target;
selecting at least one of such disease-related pathways wherein the known therapy target is also comprised within a second disease-related pathway; and
identifying treatment of the second disease as a new use for the known therapy.
- querying the database to identify a disease-related pathway comprising a known therapy target;
-
46. A method for prioritizing candidate development compounds for further development that comprises the steps of providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
- querying the database to identify all pathways associated with the target of each candidate development compound and assigning higher priority to development compounds on the basis of whether or not they are likely to result in an undesirable effect based on their involvement in other biological pathways.
-
47. A method for identifying disease-related pathways wherein the disease is a side effect of drug therapy that comprises the steps of providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
- identifying the disease-related pathway affected by a drug or drug discovery target;
querying the database to identify alternative pathways that are also affected by the drug or the drug discovery target and that result in the undesirable phenotype.
- identifying the disease-related pathway affected by a drug or drug discovery target;
-
48. A method for identifying or validating a genotypic marker for a disease state that comprises providing a means for storing and accessing genomics information in a database wherein said means permits computational analysis of biological relationships among the stored concepts;
- querying the database to identify a genotypic marker that is associated with a disease state.
-
49. A method for identifying a drug discovery target which comprises querying a computer system to identify a disease-related pathway and identifying the biological interactions and actor concepts in the disease-related pathway whereby at least one of the actor concepts involved in each such reaction is a drug discovery target and wherein the computer system comprises a means for storing and accessing genomics information in a database and a means for computational analysis of biological relationships among the stored concepts.
-
50. A method of conducting business that comprises receiving compensation from a customer in return for identifying to the customer a drug discovery target discovered by querying a computer system to identify a disease-related pathway and identifying the biological interactions and actor concepts in the disease-related pathway whereby each of the actor concepts involved in each such reaction is a drug discovery target and wherein the computer system comprises a means for storing and accessing genomics information in a database and a means for computational analysis of biological relationships among the stored concepts.
-
52. A method of drug discovery that comprises:
-
(a) identifying a drug discovery target discovered by querying a computer system to identify a disease-related pathway and identifying the biological interactions and actor concepts in the disease-related pathway whereby one or more of the actor concepts involved in each such reaction is a drug discovery target and wherein the computer system comprises a means for storing and accessing genomics information in a database and a means for computational analysis of biological relationships among the stored concepts; and
(b) screening compounds against a drug discovery target to identify drug candidates. - View Dependent Claims (53)
-
Specification